-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment_research-protocol.pdf
September 13, 2012 - less common types of venous ulcers: genetically
determined ulcers (e.g., congenital venous disease, sickle … cell disease, and inherited
thrombophilias); ulcers resulting from trauma in patients without signs … less common types of venous ulcers: genetically
determined ulcers (e.g., congenital venous disease, sickle … cell disease, and
inherited thrombophilias); ulcers resulting from trauma in patients without signs
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-chronic-pain-surveillance-report-2.pdf
April 01, 2022 - of pain (e.g., neuropathic, musculoskeletal [including low back pain],
visceral pain, fibromyalgia, sickle … cell disease, inflammatory pain,
headache disorders, and degree of nociplasticity); (2) patient demographics … pain
(e.g., neuropathic, musculoskeletal [including low back pain], visceral pain,
fibromyalgia, sickle … cell disease, inflammatory pain, headache disorders,
and degree of nociplasticity); (2) patient demographics … Adjuvant
interventions with opioids for vaso-
occlusive crisis in sickle cell disease: A
mixed treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonopioid-pharm-chronic-pain-protocol.pdf
February 01, 2019 - Neuropathic
• Musculoskeletal (low back pain, neck pain
and osteoarthritis)
• Fibromyalgia
• Sickle … cell disease
• Inflammatory arthritis (e.g., rheumatoid
arthritis)
• Chronic headachea
• Pain
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia-2011_research-protocol.pdf
January 01, 2011 - energy
malnutrition secondary to an inflammatory state, hemoglobinopathies [e.g., thalassemia
and sickle … cell anemia])
Route of iron administration (i.e., oral or intravenous)
Treatment regimen (i.e
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioids-chronic-pain-surveillance-report-1-final.pdf
April 01, 2022 - of pain (e.g., neuropathic, musculoskeletal [including low back pain],
visceral pain, fibromyalgia, sickle … cell disease, inflammatory pain,
headache disorders, and degree of nociplasticity); (2) patient demographics … pain
(e.g., neuropathic, musculoskeletal [including low back pain], visceral pain,
fibromyalgia, sickle … cell disease, inflammatory pain, headache disorders,
and degree of nociplasticity); (2) patient demographics … Adjuvant
interventions with opioids for vaso-
occlusive crisis in sickle cell disease: A
mixed treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-opioid-stewardship-protocol.pdf
July 01, 2023 - all clinical
populations, we will include populations not included in the
CDC guidelines, such as sickle … cell disease, cancer-related
pain treatment, palliative care, and end-of-life care.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-pain-opioid-treatment_research-protocol.pdf
December 19, 2013 - type or cause of pain
(e.g., neuropathic, musculoskeletal [including low back pain], fibromyalgia, sickle … cell disease, inflammatory pain, and headache disorders); 2) patient demographics
(e.g., age, race … specific type or cause of pain (e.g.,
neuropathic, musculoskeletal [including back pain], fibromyalgia, sickle … cell disease,
inflammatory pain, headache disorders); 2) patient demographics; 3) patient
Source:
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin-future_research.pdf
August 01, 2014 - patient with chronic illness presenting with suspected bacterial
pneumonia (e.g., in cystic fibrosis, sickle … cell disease)
2. … Procalcitonin is
more useful than C-reactive
protein in differentiation of
fever in patients with sickle … cell disease. … cell disease)
3 7
7.1.
-
effectivehealthcare.ahrq.gov/health-topics/bone-marrow-transplantation
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-chronic-pain-surveillance-report-3.pdf
June 01, 2022 - of pain (e.g., neuropathic, musculoskeletal [including low back pain],
visceral pain, fibromyalgia, sickle … cell disease, inflammatory pain,
headache disorders, and degree of nociplasticity); (2) patient demographics … pain
(e.g., neuropathic, musculoskeletal [including low back pain], visceral pain,
fibromyalgia, sickle … cell disease, inflammatory pain, headache disorders,
and degree of nociplasticity); (2) patient demographics … Adjuvant
interventions with opioids for vaso-
occlusive crisis in sickle cell disease: A
mixed treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-240-acute-pain-revised-comments.pdf
December 29, 2020 - management, but also include ER or pre-
discharge analgesia, and creates a
separate exception for sickle … cell disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_executive.pdf
September 19, 2014 - type or cause of pain (e.g., neuropathic,
musculoskeletal [including low back pain],
fibromyalgia, sickle … cell disease, inflammatory pain,
and headache disorders); (2) patient demographics (e.g.,
age, race … cell disease,
inflammatory pain, headache disorders); (2) patient
demographics; (3) patient comorbidities … cell disease, inflammatory pain,
and headache disorders); (2) patient demographics
(e.g., age, race … cell disease, inflammatory pain, headache
disorders); (2) patient demographics; (3) patient
comorbidities
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2023.pdf
January 01, 2023 - Dental Care for Persons With Sickle Cell Disease
8.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-2.xlsx
September 30, 2015 - Appendix Table D-1. RCTs
Table D-1. Randomized controlled trials
Author, Year Study Design
Duration Setting
Country Eligibility Criteria Interventions Sample Characteristics Screened
Eligible
Randomized
Analyzed Results Adverse Events and Withdrawals Due to Adverse Events Sponsor Quality
Hruschak, 2021 RCT
Duration:…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveill-report-1.xlsx
September 30, 2015 - Appendix Table D-1. RCTs
Table D-1. Randomized controlled trials
Author, Year Study Design
Duration Setting
Country Eligibility Criteria Interventions Sample Characteristics Screened
Eligible
Randomized
Analyzed Results Adverse Events and Withdrawals Due to Adverse Events Sponsor Quality
Hruschak, 2021 RCT
Duration:…
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-229-opioid-treatments-chronic-pain-evidence-summary.pdf
April 01, 2020 - pain (e.g.,
neuropathic, musculoskeletal [including low
back pain], visceral pain, fibromyalgia, sickle … cell disease, inflammatory pain, headache
disorders, and degree of nociplasticity); (2)
patient demographics … pain (e.g., neuropathic,
musculoskeletal [including low back pain],
visceral pain, fibromyalgia, sickle … cell disease,
inflammatory pain, headache disorders,
and degree of nociplasticity); (2) patient
demographics
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_disposition-comments.pdf
April 25, 2013 - systemic sclerosis) that may be candidates for
screening test studies, including patients with HIV, sickle … cell anemia or trait, portal hypertension, family history of
PAH or catecholaminergic drug use. … KQ1L For echocardiography, screening populations were SSc,
liver transplant and Sickle cell disease. … I have some concerns about the inclusion of
Sickle cell disease because of the multi-faceted causes
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/engaging-caregivers-appendix-b.xlsx
May 29, 2025 - Table B-1. Evidence Table
Table B-1. Details of included studies
Author, Year Study Design Country Setting/Transition Adult, Adolescent, or Pediatric Patients Inclusion/Exclusion Criteria Condition Caregiver Details Patient Age, Years
(Mean, Unless Specified) Caregiver Age, Years
(Mean, Unless Specified) Patient Fe…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/plant-based-treatments-revised-protocol.pdf
March 29, 2023 - including low-back pain), visceral pain, fibromyalgia,
inflammatory arthritis, headache disorders, sickle … cell disease, and cancer pain (non-end
of life)
• Degree of nociplasticity/central sensitization
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/acute-pain-protocol-amended.pdf
June 10, 2018 - Research Protocol (Amended): Treatment of Acute Pain--An Evidence Map
Evidence-based Practice Center Technical Brief Protocol
Project Title: Treatment of Acute Pain – An Evidence Map
I. Background and Objectives for the Technical Brief
Addressing the opioid epidemic in the United States is a key prior…